Search clinical trials for: epoetin beta [NeoRecormon]

Total 6524 results

University of Florida
Ortho Biotech Clinical Affairs, L.L.C.

Completed

Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer

Anemia

United States
Hospital Son Espases

Recruiting

Paricalcitol Improves Anemia of Inflammation (PIERAID)

Anemia

Spain
Biogen
AbbVie

Completed

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis ((DECIDE))

Relapsing-Remitting Multiple Sclerosis

Sweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Lymphoma | Leukemia | Anemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
Region Skane

Completed

Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery (EPRICS)

Renal Failure | Kidney Failure

Sweden
Kind Pharmaceuticals LLC

Active, not recruiting

A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis

Renal Anemia

United States
Anemia Working Group Romania
Dr Carol Davila Teaching Hospital of Nephrology; Romanian Renal Registry

Withdrawn

Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules (VAES)

Bio-Equivalency of 2 Treatment Schedules in HD Patients

Romania
Ortho Biotech Products, L.P.

Completed

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

Anemia | Chemotherapy
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy (Neurepo)

Hypoxic Ischemic Encephalopathy

France
Northwestern University

Active, not recruiting

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

Liver Transplant Rejection

United States
Azidus Brasil

Completed

PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.

Healthy

Brazil
Alexandria University

Completed

Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy

Optic Neuropathy

Egypt
Mehrotra, Anita, M.D.
Icahn School of Medicine at Mount Sinai

Terminated

Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

Anemia

United States
Ortho Biotech Products, L.P.

Completed

A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)

Anemia | Chronic Renal Insufficiency
National Institute on Aging (NIA)

Terminated

Idiopathic Anemia of Aging (IAA)

Anemia | Aging

United States
United States Army Research Institute of Environmental...

Completed

Impact of Erythropoietin on Hematological Adaptations and Physical Performance

Physical Performance | Exercise-Induced Anemia

United States
Shire

Terminated

Dynepo Long-Term Safety Study

Anemia | Kidney Failure, Chronic

Belgium
Mayo Clinic
National Cancer Institute (NCI)

Completed

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Lymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder

United States
Boston University

Completed

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

Beta-Thalassemia

United States, United Kingdom
European Organisation for Research and Treatment...

Unknown

Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes | Anemia

Belgium, Switzerland, Czech Republic, Portugal, Austria, Netherlands, Slovakia
Vifor Fresenius Medical Care Renal Pharma
Worldwide Clinical Trials; Fresenius Medical Care Deutschland GmbH

Terminated

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial (ANEMEX)

Anemia | End Stage Renal Disease

United Kingdom
Takeda
Affymax

Completed

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis (DIAMOND)

Anemia | Chronic Kidney Disease

United States
Bio Sidus SA

Unknown

Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease

Anemia of Chronic Kidney Disease

Argentina, Paraguay
Hospital General de Niños Pedro de Elizalde

Completed

Erythropoietin in Hemolytic Uremic Syndrome

Anemia | Hemolytic-Uremic Syndrome

Argentina
Medical College of Wisconsin

Withdrawn

Erythropoietin Effects After Traumatic Brain Injury

Traumatic Brain Injury

United States
Merck Sharp & Dohme LLC

Terminated

A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)

Anemia | Chronic Kidney Disease
Assiut University

Unknown

Prognostic Value of Serum Erythropoietin Level,Ferritin Level and Fibrinogen in Adult Low Risk MDS

MDS
Hospital Authority, Hong Kong
The Hong Kong Society of Nephrology

Completed

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

Cardiovascular Diseases | Kidney Diseases | Chronic Disease

China
West Penn Allegheny Health System

Completed

Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation

Delayed Graft Function

United States
University of Louisville
James Graham Brown Cancer Center

Withdrawn

Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia (Procrit)

Anemia

United States
Northwestern University
Icahn School of Medicine at Mount Sinai; Mount Sinai Hospital, New York

Completed

Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease

Autoimmune Hepatitis

United States
Mahidol University

Completed

Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients (CUAEPO)

Chronic Renal Failure

Thailand
Kyoto Prefectural University of Medicine

Unknown

Anti-Restenosis After AMI by Erythropoietin

Acute Myocardial Infarction

Japan
Hammersmith Hospitals NHS Trust

Unknown

Erythropoietin in Acute Myocardial Infarction

Acute Myocardial Infarction

United Kingdom
Janssen Research & Development, LLC

Completed

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Breast Cancer | Neoplasm Metastasis

United States, Poland, Ukraine, Taiwan, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Russian Federation, South Africa, Hong Kong, Chile, Brazil, Philippines, Ecuador, Macedonia, The Former Yugoslav Republic... and more
Imperial College Healthcare NHS Trust

Completed

Treatment Response in Dialysis Anaemia (PRIME)

Anaemia | Haemodialysis

United Kingdom
University of California, San Diego

Terminated

Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial

Anemia | Congenital Heart Disease | Cyanotic Congenital Heart Disease | Cyanosis

United States
University of New Mexico
University of Colorado, Denver; Thrasher Research Fund; Intermountain Health...

Completed

Darbepoetin Administration to Preterm Infants

Infant, Newborn

United States
University of Copenhagen

Completed

Tracing Changed Production of Red Blood Cells

Erythrocytosis | Erythropoiesis Abnormal

Denmark
Uniformed Services University of the Health Sciences
National Institutes of Health (NIH)

Withdrawn

Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI (TBI-EPO)

Traumatic Brain Injury

United States
Globe Biotech Limited

Completed

A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002

Natural Blood and Blood Product Toxicity

Bangladesh
University of Louisville
Ortho Biotech, Inc.

Withdrawn

Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations

Cancer

United States
Morten Hostrup, PhD
University of Tasmania

Unknown

Exosome Proteomics to Detect EPO

Healthy

Denmark
M.D. Anderson Cancer Center
Centocor, Inc.

Completed

A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS

Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
FibroGen
Peking University First Hospital; Peking Union Medical College Hospital; First... and other collaborators

Completed

Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China

Anemia in End Stage Renal Disease

China
Azidus Brasil

Unknown

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.

Healthy

Brazil
Brigham and Women's Hospital
Ortho Biotech Products, L.P.

Terminated

Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial (ERIN)

Contrast Induced Nephropathy

United States
Sunnybrook Health Sciences Centre

Completed

Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity

Anemia | Hemodialysis | Chronic Renal Failure
Labbafinejhad Hospital
Shahid Beheshti University of Medical Sciences

Unknown

The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group

Transplantation, Kidney
Ontario Clinical Oncology Group (OCOG)
Ortho Biotech, Inc.

Terminated

Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)

Anemia | Lung Cancer | Non-Small-Cell Lung Carcinoma

Canada

Search clinical trials for: epoetin beta [NeoRecormon]

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations